Newsletter Archive

31. 06.22.21 -- Increase Your Decentralized Trial Success Rate 6/22/2021

    06/22/21 Clinical Leader Newsletter

32. 06.21.21 -- ICER: FDA Has Failed In It's Responsibility To Protect Patients From Harm 6/21/2021
    06/21/21 Clinical Leader Newsletter
33. 06.21.21 -- Putting Patients First: Advocacy, Diversity & Inclusion, And Decentralized Trials 6/21/2021
    06/21/21 Clinical Leader Newsletter
34. 06.17.21 -- How To Manage The Site Selection And Feasibility Process 6/17/2021

    06/17/21 Clinical Leader Newsletter

35. 06.16.21 -- What Does Biogen's Drug Approval Mean For Alzheimer's Patients? 6/16/2021
    06/16/21 Clinical Leader Newsletter
36. 06.16.21 -- How To Identify Choice Clinical Trial Designs 6/16/2021

    06/16/21 Clinical Leader Newsletter

37. 06.15.21 -- Accelerate Timelines By Planning For Clinical Supplies In Advance 6/15/2021

    06/15/21 Clinical Leader Newsletter

38. 06.15.21 -- Unburden Your Sites For Better Clinical Trials 6/15/2021

    06/15/21 Clinical Leader Newsletter

39. 06.14.21 -- Severe Disease Increases Necessity For A Patient-Centric Approach 6/14/2021
    06/14/21 Clinical Leader Newsletter
40. 06.14.21 -- Device Strategy For eCOA: BYOD Or Provisioned? 6/14/2021

    06/14/21 Clinical Leader Newsletter